Increase in Common Stock Dividend
As previously announced, on September 27, 2007, the Company declared a dividend of twenty-eight cents ($0.28) per share on the outstanding shares of its common stock, payable on December 3, 2007 to stockholders of record at the close of business on November 13, 2007. This quarterly rate represents a 7.7% increase per share from the previous quarter ($0.26).
The following table sets forth worldwide net revenue by reportable segment together with the percentage changes from the comparable period in the prior year:
Three Months Ended Nine Months Ended
Net Revenue By
Reportable Segment ($ in millions) Increase ($ in millions) Increase
Pharmaceuticals $4,670 10% $13,898 10%
Consumer Healthcare 715 8% 1,949 7%
Animal Health 235 11% 789 8%
Consolidated Total $5,620 9% $16,636 10%
Worldwide Pharmaceuticals net revenue increased 10% for the 2007 third
quarter and first nine months due primarily to higher sales of Effexor,
Prevnar, Enbrel, Nutrition products and Zosyn(R). Protonix(R) sales
decreased 6% for the 2007 third quarter, reflecting
Copyright©2007 PR Newswire.
All rights reserved